Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Topical Dehydrex in Treating Recurrent Corneal Erosion
This is a compassionate-use treatment study to provide Dehydrex to patients with corneal erosion syndrome who have previously used Dehydrex.
100 Clinical Results associated with Holles Laboratories, Inc.
0 Patents (Medical) associated with Holles Laboratories, Inc.
100 Deals associated with Holles Laboratories, Inc.
100 Translational Medicine associated with Holles Laboratories, Inc.